Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MHC transmission: insights into gender bias in MS susceptibility.
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Gender and the hygiene hypothesis.
Teriflunomide modest help but safe for MS
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
GlaxoSmithKline Protocol Summaries: Firategrast
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
IL-17 and Th17 Cells.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
The natural history of primary progressive MS in British Columbia, Canada.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Testosterone treatment in multiple sclerosis: a pilot study.

Pages